Sirolimus in Kidney Transplant Donors and Clinical and Histologic Improvement in Recipients: Rat Model

Transplantation Proceedings

Volumn 42, Issue 1, 2010, Pages 365-370

  Cicora, F ^a,b,c   Lausada, N ^a   Vasquez, D N ^c   Cicora, P ^c   Zalazar, G ^a   Gonzalez, P ^d   Palti, G ^b   Raimondi, C ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b HOSPITAL ALEMÁN   (Argentina)

^c Foundation for the Research   (Argentina)

^d Universidad Provincial del Sudoeste   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BUPRENORPHINE; CREATININE; DIAZEPAM; PROTEIN BCL 2; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GRAFT RECIPIENT; HISTOLOGY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SINGLE DRUG DOSE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UPREGULATION;

ANIMALS; COMPLEMENT C3; CREATININE; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY MEDULLA; KIDNEY TRANSPLANTATION; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; SIROLIMUS; TUMOR NECROSIS FACTOR-ALPHA; UREA;

EID: 76749114693     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.11.013     Document Type: Article

References (38)

1. Perico N., Cattaneo D., Sayegh M.H., et al. Delayed graft function in kidney transplantation. Lancet 364 (2004) 1814
2. Peeters P., Terryn W., Vanholder R., et al. Delayed graft functioning in renal transplantation. Curr Opin Crit Care 10 (2004) 489
3. Tilney N.L., and Guttman R.D. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 64 (1997) 945
4. Sehgal S.N. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 31 (1998) 335
5. Kahan B.D. Sirolimus: a comprehensive review. Expert Opin Pharmacother 2 (2001) 1903
6. Mollnes T.E., and Fosse E. The complement system in trauma-related and ischemic tissue damage: a brief review. Shock 2 (1994) 301
7. Barrington R., Zhang M., Fischer M., et al. The role of complement in inflammation and adaptive immunity. Immunolog Rev 180 (2001) 5
8. Kirschfink M. Targeting complement in therapy. Immunologic Rev 180 (2001) 177
9. Morgan B.P., and Gasque P. Extrahepatic complement biosynthesis: where, when and why?. Clin Exp Immunol 107 (1997) 1
10. Thurman J.M., Royer P.A., Ljubanovic D., et al. Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. J Am Soc Nephrol 17 (2006) 707
11. Zheng X., Zhang X., Sun H., et al. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 82 (2006) 1781
12. Kaushal G.P., Basnakian A.G., and Shah S.V. Apoptotic pathways in ischemic acute renal failure. Kidney Int 66 (2004) 500
13. Hughes J., and Savill J.S. Apoptosis in glomerulonephritis. Curr Opin Nephrol Hypertens 14 (2005) 389
14. Launay S., Hermine O., Fontenay M., et al. Vital functions for lethal caspases. Oncogene 24 (2005) 5137
15. Peralta Soler A., Mullin J.M., Knudsen K.A., et al. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am J Physiol 27 (1996) F869
16. Dong X., Swaminathan S., Bachman L.A., et al. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 71 (2007) 619
17. Wolfs T., de Vries B., Walter S.J., et al. Apoptotic cell death is initiated during normothermic ischemia in human kidneys. Am J of transplantation 5 (2005) 68
18. Lui S.L., Chan K.W., Tsang R., et al. Effect of rapamycin on renal ischemia-reperfusion injury in mice. Transpl Int 19 (2006) 834
19. Ventura C.G., Coimbra T.M., de Campos S.B., et al. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury. J Am Soc Nephrol 13 (2002) 2524
20. Cicora F, Greco G, Lausada N, et al: Preconditioning with Immunosuppressive Drugs Reduces the Expression of Systemic C3 and Local Pro-Inflammatory Cytokines in Renal Ischemia Reperfusion Injury. Abstract 1206, ATC, Toronto, 2008
21. Reutzel-Selke A., Zschockelt T., Denecke C., et al. Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/reperfusion injury and long-term graft function in renal allografts from older donors. Transplantation 75 (2003) 1786
22. Kohli V., Selzner M., Madden J.F., et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia reperfusion injury in the rat liver. Transplantation 67 (1999) 1099
23. Gottlieb R.A., Burleson K.O., Kloner R.A., et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94 (1994) 1621
24. Li Y., Chopp M., Jiang N., et al. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke 26 (1995) 1252
25. Schumer M., Colombel M.C., Sawczuk I.S., et al. Morphologic, biochemical and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140 (1992) 831
26. Donnahoo K.K., Shames B.D., Harken A.H., et al. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 162 (1999) 196
27. Isaka Y., Suzuki C., Abe T., et al. Bcl-2 protects tubular epithelial cells from ischemia/reperfusion injury by dual mechanisms. Transplant Proc 41 (2009) 52
28. Yang B., Jain S., Ashra S.Y., et al. Apoptosis and caspase-3 in long-term renal ischemia/reperfusion injury in rats and divergent effects of immunosuppressants. Transplantation 81 (2006) 1442
29. Serr F., Lauer H., Armann B., et al. Sirolimus improves early microcirculation, but impairs regeneration after pancreatic ischemia-reperfusion injury. Am J Transplant 7 (2007) 48
30. Fuller T.F., Freise C.E., Serkova N., et al. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 76 (2003) 1594
31. Loverre A., Ditonno P., Crovace A., et al. Ischemia reperfusion induces glomerular and tubular activation of proinflamatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol 15 (2004) 2675
32. Sacks S.H., and Zhou W. Locally produced complement and its role in renal allograft rejection. Am J Transplant 3 (2003) 927
33. de Vries B., Walter S.J., Peutz-Kootstra C.J., et al. The mannose-binding lectin pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 165 (2004) 1677
34. Lin T., Zhou W., and Sacks S.H. The role of complement and Toll-like receptors in organ transplantation. Transpl Int 20 (2007) 481
35. David S., Biancone L., Caserta C., et al. Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 12 (1997) 51
36. Zheng X., Feng B., Chen G., et al. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant 6 (2006) 2099
37. Kunzendorf U., Hohenstein B., Oberbarnscheid M., et al. Duration of donor brain death and its influence on kidney graft function. Am J Transplant 2 (2002) 292
38. Morariu A.M., Schuurs T.A., Leuvenink H.G., et al. Early events in kidney donation: progression of endothelial activation, oxidative stress and tubular injury after brain death. Am J Transplant 8 (2008) 933